News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
17,440 Results
Type
Article (2419)
Company Profile (1)
Press Release (15020)
Section
Business (3178)
Career Advice (16)
Deals (405)
Drug Delivery (6)
Drug Development (4638)
Employer Resources (2)
FDA (387)
Job Trends (276)
News (7726)
Policy (622)
Tag
Academia (244)
Adcomms (7)
Allergies (1)
Alliances (999)
ALS (11)
Alzheimer's disease (1160)
Approvals (404)
Artificial intelligence (18)
Autoimmune disease (1)
Bankruptcy (3)
Best Places to Work (257)
Biotechnology (2)
Bladder cancer (2)
Brain cancer (2)
Breast cancer (2)
Cancer (31)
Cardiovascular disease (8)
Career advice (15)
CAR-T (4)
Cell therapy (27)
Clinical research (3534)
Collaboration (47)
Compensation (6)
Complete response letters (2)
COVID-19 (99)
CRISPR (2)
C-suite (14)
Cystic fibrosis (1)
Data (378)
Depression (25)
Diabetes (11)
Diagnostics (154)
Digital health (1)
Diversity (1)
Diversity, equity & inclusion (1)
Drug discovery (7)
Drug pricing (2)
Duchenne muscular dystrophy (5)
Earnings (1250)
Editorial (3)
Employer resources (2)
Events (2485)
Executive appointments (8)
FDA (552)
Frontotemporal dementia (6)
Funding (57)
Gene editing (3)
Gene therapy (31)
GLP-1 (38)
Government (107)
Guidances (5)
Healthcare (505)
Huntington's disease (24)
Immunology and inflammation (14)
Indications (7)
Infectious disease (100)
Inflammatory bowel disease (1)
Influenza (1)
Intellectual property (12)
Interviews (2)
IPO (166)
IRA (1)
Job creations (32)
Job search strategy (14)
JPM (1)
Layoffs (17)
Leadership (1)
Legal (52)
Longevity (1)
Lung cancer (7)
Lymphoma (3)
Management (1)
Manufacturing (5)
MASH (2)
Medical device (244)
Medtech (245)
Mergers & acquisitions (254)
Metabolic disorders (31)
Multiple sclerosis (21)
Neurodegenerative disease (122)
Neuropsychiatric disorders (32)
Neuroscience (1458)
Neurotech (1)
NextGen: Class of 2026 (170)
Non-profit (163)
Obesity (13)
Opinion (12)
Pain (9)
Parkinson's disease (84)
Partnered (2)
Patents (17)
Patient recruitment (27)
People (857)
Phase 1 (939)
Phase 2 (1862)
Phase 3 (1174)
Pipeline (210)
Policy (3)
Postmarket research (87)
Preclinical (437)
Prostate cancer (4)
Psychedelics (8)
Radiopharmaceuticals (6)
Rare diseases (64)
Real estate (53)
Regulatory (694)
Reports (1)
Research institute (162)
Resumes & cover letters (1)
Rett syndrome (8)
RSV (1)
Schizophrenia (81)
Series A (12)
Series B (5)
Sickle cell disease (1)
Special edition (3)
Spinal muscular atrophy (6)
Sponsored (1)
Startups (81)
Supply chain (1)
The Weekly (2)
Vaccines (21)
Venture capital (2)
Weight loss (6)
Women's health (2)
Date
Today (3)
Last 7 days (26)
Last 30 days (69)
Last 365 days (1126)
2026 (106)
2025 (1134)
2024 (1428)
2023 (1463)
2022 (1769)
2021 (1624)
2020 (1216)
2019 (1202)
2018 (894)
2017 (777)
2016 (883)
2015 (1046)
2014 (741)
2013 (497)
2012 (433)
2011 (417)
2010 (429)
Location
Africa (16)
Alabama (1)
Arizona (6)
Asia (1108)
Australia (329)
California (315)
Canada (110)
China (18)
Colorado (7)
Connecticut (18)
Europe (2576)
Florida (130)
Georgia (8)
Idaho (1)
Illinois (27)
Indiana (33)
Japan (60)
Kansas (6)
Kentucky (1)
Maine (1)
Maryland (53)
Massachusetts (390)
Michigan (3)
Minnesota (6)
Missouri (10)
Nebraska (2)
Nevada (21)
New Jersey (114)
New Mexico (1)
New York (283)
North Carolina (15)
Northern California (152)
Ohio (12)
Oregon (5)
Pennsylvania (53)
Puerto Rico (1)
Rhode Island (1)
South America (26)
Southern California (124)
Tennessee (1)
Texas (71)
United States (1571)
Utah (12)
Washington D.C. (1)
Washington State (26)
17,440 Results for "umecrine cognition".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cognition Therapeutics Extends Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
February 5, 2026
·
7 min read
Press Releases
Feinstein Institutes’ Research Pinpoints Core Cause of Vascular Cognitive Impairment, Unlocking New Therapeutic Avenues for Cognitive Decline
December 8, 2025
·
3 min read
Press Releases
Cognition Therapeutics Completes Type C Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies
January 28, 2026
·
6 min read
Press Releases
Alpha Cognition Provides 2026 Corporate Update Highlighting Strategic Priorities and 2025 Commercial Execution
January 8, 2026
·
8 min read
Press Releases
Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners
December 2, 2025
·
4 min read
Press Releases
Cognition Therapeutics to Participate in 37th Annual Piper Sandler Healthcare Conference
November 21, 2025
·
4 min read
Press Releases
Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine’s Potential to Slow the Progression of Dementia with Lewy Bodies
January 6, 2026
·
8 min read
Press Releases
Cognition Therapeutics Reaches Full Enrollment in Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
December 3, 2025
·
7 min read
Press Releases
Alpha Cognition to Present Clinical Data at ASCP Annual Meeting
October 7, 2025
·
7 min read
Press Releases
Cognition Therapeutics Completes Enrollment in Phase 2 Study of Zervimesine (CT1812) in Early Alzheimer’s Disease
November 14, 2025
·
8 min read
1 of 1,744
Next
